nodes	percent_of_prediction	percent_of_DWPC	metapath
Reserpine—Voacamine—Vinblastine—head and neck cancer	0.635	1	CrCrCtD
Reserpine—ABCB11—Vinblastine—head and neck cancer	0.115	0.319	CbGbCtD
Reserpine—SLC22A2—Vinblastine—head and neck cancer	0.0741	0.206	CbGbCtD
Reserpine—ABCC2—Vinblastine—head and neck cancer	0.0605	0.168	CbGbCtD
Reserpine—ABCC2—Docetaxel—head and neck cancer	0.0499	0.138	CbGbCtD
Reserpine—CYP3A5—Docetaxel—head and neck cancer	0.025	0.0693	CbGbCtD
Reserpine—ABCB1—Vinblastine—head and neck cancer	0.0197	0.0547	CbGbCtD
Reserpine—ABCB1—Docetaxel—head and neck cancer	0.0163	0.0451	CbGbCtD
Reserpine—Parkinsonism—Fluorouracil—head and neck cancer	0.000402	0.0848	CcSEcCtD
Reserpine—Deafness—Vinblastine—head and neck cancer	0.000226	0.0477	CcSEcCtD
Reserpine—Angina pectoris—Vinblastine—head and neck cancer	0.00017	0.0359	CcSEcCtD
Reserpine—Dysuria—Hydroxyurea—head and neck cancer	0.000149	0.0314	CcSEcCtD
Reserpine—Weight increased—Hydroxyurea—head and neck cancer	0.000145	0.0306	CcSEcCtD
Reserpine—Drowsiness—Hydroxyurea—head and neck cancer	0.000142	0.03	CcSEcCtD
Reserpine—Angina pectoris—Fluorouracil—head and neck cancer	0.000112	0.0236	CcSEcCtD
Reserpine—Deafness—Docetaxel—head and neck cancer	0.000107	0.0226	CcSEcCtD
Reserpine—Epistaxis—Fluorouracil—head and neck cancer	9.64e-05	0.0203	CcSEcCtD
Reserpine—Anorexia—Vinblastine—head and neck cancer	9.47e-05	0.02	CcSEcCtD
Reserpine—Oedema—Hydroxyurea—head and neck cancer	9.06e-05	0.0191	CcSEcCtD
Reserpine—Anorexia—Hydroxyurea—head and neck cancer	8.63e-05	0.0182	CcSEcCtD
Reserpine—Decreased appetite—Vinblastine—head and neck cancer	8.63e-05	0.0182	CcSEcCtD
Reserpine—Pain—Vinblastine—head and neck cancer	8.49e-05	0.0179	CcSEcCtD
Reserpine—Arrhythmia—Fluorouracil—head and neck cancer	8.2e-05	0.0173	CcSEcCtD
Reserpine—Dyspnoea—Hydroxyurea—head and neck cancer	8.07e-05	0.017	CcSEcCtD
Reserpine—Angina pectoris—Docetaxel—head and neck cancer	8.06e-05	0.017	CcSEcCtD
Reserpine—Somnolence—Hydroxyurea—head and neck cancer	8.05e-05	0.017	CcSEcCtD
Reserpine—Decreased appetite—Hydroxyurea—head and neck cancer	7.87e-05	0.0166	CcSEcCtD
Reserpine—Pain—Hydroxyurea—head and neck cancer	7.74e-05	0.0163	CcSEcCtD
Reserpine—Weight increased—Docetaxel—head and neck cancer	7.53e-05	0.0159	CcSEcCtD
Reserpine—Epistaxis—Docetaxel—head and neck cancer	6.96e-05	0.0147	CcSEcCtD
Reserpine—Diarrhoea—Vinblastine—head and neck cancer	6.79e-05	0.0143	CcSEcCtD
Reserpine—Dizziness—Vinblastine—head and neck cancer	6.57e-05	0.0139	CcSEcCtD
Reserpine—Oedema—Fluorouracil—head and neck cancer	6.52e-05	0.0138	CcSEcCtD
Reserpine—Vomiting—Vinblastine—head and neck cancer	6.31e-05	0.0133	CcSEcCtD
Reserpine—Headache—Vinblastine—head and neck cancer	6.22e-05	0.0131	CcSEcCtD
Reserpine—Anorexia—Fluorouracil—head and neck cancer	6.21e-05	0.0131	CcSEcCtD
Reserpine—Diarrhoea—Hydroxyurea—head and neck cancer	6.2e-05	0.0131	CcSEcCtD
Reserpine—Dizziness—Hydroxyurea—head and neck cancer	5.99e-05	0.0126	CcSEcCtD
Reserpine—Arrhythmia—Docetaxel—head and neck cancer	5.92e-05	0.0125	CcSEcCtD
Reserpine—Nausea—Vinblastine—head and neck cancer	5.9e-05	0.0124	CcSEcCtD
Reserpine—Dyspnoea—Fluorouracil—head and neck cancer	5.81e-05	0.0123	CcSEcCtD
Reserpine—Somnolence—Fluorouracil—head and neck cancer	5.79e-05	0.0122	CcSEcCtD
Reserpine—Vomiting—Hydroxyurea—head and neck cancer	5.76e-05	0.0122	CcSEcCtD
Reserpine—Rash—Hydroxyurea—head and neck cancer	5.71e-05	0.012	CcSEcCtD
Reserpine—Dermatitis—Hydroxyurea—head and neck cancer	5.7e-05	0.012	CcSEcCtD
Reserpine—Headache—Hydroxyurea—head and neck cancer	5.67e-05	0.012	CcSEcCtD
Reserpine—Decreased appetite—Fluorouracil—head and neck cancer	5.67e-05	0.012	CcSEcCtD
Reserpine—Pain—Fluorouracil—head and neck cancer	5.57e-05	0.0118	CcSEcCtD
Reserpine—Nausea—Hydroxyurea—head and neck cancer	5.38e-05	0.0114	CcSEcCtD
Reserpine—Syncope—Docetaxel—head and neck cancer	5.17e-05	0.0109	CcSEcCtD
Reserpine—Loss of consciousness—Docetaxel—head and neck cancer	5.07e-05	0.0107	CcSEcCtD
Reserpine—Oedema—Docetaxel—head and neck cancer	4.7e-05	0.00993	CcSEcCtD
Reserpine—Shock—Docetaxel—head and neck cancer	4.63e-05	0.00977	CcSEcCtD
Reserpine—Pruritus—Fluorouracil—head and neck cancer	4.61e-05	0.00973	CcSEcCtD
Reserpine—Anorexia—Docetaxel—head and neck cancer	4.48e-05	0.00946	CcSEcCtD
Reserpine—Diarrhoea—Fluorouracil—head and neck cancer	4.46e-05	0.00941	CcSEcCtD
Reserpine—Dizziness—Fluorouracil—head and neck cancer	4.31e-05	0.0091	CcSEcCtD
Reserpine—Dyspnoea—Docetaxel—head and neck cancer	4.19e-05	0.00885	CcSEcCtD
Reserpine—Somnolence—Docetaxel—head and neck cancer	4.18e-05	0.00883	CcSEcCtD
Reserpine—Vomiting—Fluorouracil—head and neck cancer	4.14e-05	0.00875	CcSEcCtD
Reserpine—Rash—Fluorouracil—head and neck cancer	4.11e-05	0.00867	CcSEcCtD
Reserpine—Dermatitis—Fluorouracil—head and neck cancer	4.11e-05	0.00866	CcSEcCtD
Reserpine—Decreased appetite—Docetaxel—head and neck cancer	4.09e-05	0.00863	CcSEcCtD
Reserpine—Headache—Fluorouracil—head and neck cancer	4.08e-05	0.00862	CcSEcCtD
Reserpine—Pain—Docetaxel—head and neck cancer	4.02e-05	0.00849	CcSEcCtD
Reserpine—Nausea—Fluorouracil—head and neck cancer	3.87e-05	0.00817	CcSEcCtD
Reserpine—Pruritus—Docetaxel—head and neck cancer	3.33e-05	0.00702	CcSEcCtD
Reserpine—Diarrhoea—Docetaxel—head and neck cancer	3.22e-05	0.00679	CcSEcCtD
Reserpine—Dizziness—Docetaxel—head and neck cancer	3.11e-05	0.00656	CcSEcCtD
Reserpine—Vomiting—Docetaxel—head and neck cancer	2.99e-05	0.00631	CcSEcCtD
Reserpine—Rash—Docetaxel—head and neck cancer	2.97e-05	0.00626	CcSEcCtD
Reserpine—Dermatitis—Docetaxel—head and neck cancer	2.96e-05	0.00625	CcSEcCtD
Reserpine—Headache—Docetaxel—head and neck cancer	2.95e-05	0.00622	CcSEcCtD
Reserpine—Nausea—Docetaxel—head and neck cancer	2.79e-05	0.0059	CcSEcCtD
